Litcius/Paper detail

BCMA T-Cell Engager Therapy in Patients with Refractory Autoimmune Disease

Laura Bucci, Sebastian Boeltz, Melanie Hagen, Carlo Tur, Danae-Mona Nöthling, Tobias Rothe, Andreas Wirsching, Janina Auth, Jochen Wacker, Markus Eckstein, Stefano Alivernini, Aline Bözec, Christina Bergmann, Maria Antonietta D’Agostino, Luis E. Muñoz, Jürgen Rech, Lars Kihm, Maria Gabriella Raimondo, Georg Schett, Ricardo Grieshaber‐Bouyer

2025New England Journal of Medicine17 citationsDOI

Topics & Concepts

MedicineRefractory (planetary science)Autoimmune diseaseDiseaseInternal medicineImmunotherapyCancer researchOncologyCancerImmunologyAutoimmunityAntibody therapyMonoclonal antibodyAutoantibodyProgressive diseaseAntibodyImmune systemCAR-T cell therapy researchMonoclonal and Polyclonal Antibodies ResearchChronic Lymphocytic Leukemia Research
BCMA T-Cell Engager Therapy in Patients with Refractory Autoimmune Disease | Litcius